On the afternoon of June 1, at the Boao Forum for Asia Global Health Forum, Yichao Medical’s ultrasonic energy surgical system, in conjunction with Shandong Weigao Group’s “Miaoshou” surgical robot, successfully performed a remote nephrectomy on a pig located 300 kilometers away.
This is not the first time Yichao Medical has collaborated with the “Miaoshou” surgical robot. Two years ago, the two parties successfully partnered to perform the world’s first 5G-enabled remote surgery, smoothly removing the kidney, gallbladder, and bladder from a live animal located more than 2,000 kilometers away. Subsequently, Yichao Medical collaborated with another domestic surgical robot manufacturer to complete China’s first multi-point, collaborative, 5G-enabled remote multidisciplinary surgical experiment. Currently, Yichao Medical is exploring in-depth cooperation with domestic surgical robot companies.
As a fully self-developed ultrasonic energy surgical system, it is highly challenging to conduct remote surgeries in conjunction with China’s top-tier surgical robots. This is because remote surgery demands extremely high operational precision and imposes stringent quality requirements on the integrated surgical equipment. The fact that Yichao Medical can maintain ongoing collaborations with multiple leading domestic surgical robot companies further attests to its product quality and R&D capabilities. Ms. Shen Changzheng, Co-founder of Yichao Medical, stated that as the depth and breadth of these collaborations expand, Yichao Medical has gained clearer direction in its independent innovation strategy. The company also looks forward to engaging in comprehensive cooperation with more outstanding enterprises to jointly enhance the quality of Chinese-made medical devices and continuously advance the level of minimally invasive surgical treatment in China. This is both the vision and the responsibility of Yichao Medical!

Chen Feng Fuzhen, Chair of the Boao Forum for Asia Global Health Conference, observed Niu Haitao, Vice President of the Affiliated Hospital of Qingdao University, perform a live demonstration using the “Miaoshou” surgical robot equipped with Yichao Medical’s ultrasonic surgical system. Leveraging mobile 5G technology, Dr. Niu conducted a nephrectomy on a pig located in an operating room at a hospital in Weihai, 300 kilometers away.

Yichao Medical’s Ultrasonic Energy Surgical System features a proprietary anti-adhesion Teflon-coated tip and an ultra-thin, sharp blade design, ensuring clean and efficient cutting and hemostasis.
It is reported that in January this year, this ultrasonic energy surgical system obtained the medical device product registration certificate from the National Medical Products Administration. This product is not only the first in China and the second globally among ultrasonic energy surgical systems with anti-adhesion functionality, but also the only domestically developed ultrasonic energy surgical system featuring fully proprietary underlying technologies. Moreover, leveraging its series of matrix-based product portfolios, Yichao Medical’s ultrasonic energy surgical system is building comprehensive competitive capabilities in the market.
According to Shen Changzheng, Yichao Medical’s latest product—the groundbreaking dual-engine integrated superconducting surgical system—has entered the testing phase and is expected to begin clinical trials by the end of this year, poised to redefine the next-generation “scalpel,” a development well worth anticipating!